Enric Reverter

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Aortic Dissection

Extracorporeal Membrane Oxygenation

Hepatitis B Virus

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Annals of hematology

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Filipe S Cardoso, David Toapanta, Natalia Jimenez, Pedro Fidalgo, António Figueiredo, Miriam Valdivieso, Nuno Germano, Jody A Rule, William M Lee, Juan G Abraldes, Enric Reverter, Constantine J Karvellas
Ammonia and urea metabolism in acute liver failure: A multicentre cohort study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Enric Reverter
Editorial: when cirrhosis deserves haemodialysis-rethinking strategies. Alimentary pharmacology & therapeutics 50 (4) (2020)
Ona Escoda, Enric Reverter, Jordi To-Figueras, Gregori Casals, Javier Fernández, Santiago Nogué
Potential value of urinary amatoxin quantification in patients with hepatotoxic mushroom poisoning. Liver international : official journal of the International Association for the Study of the Liver 39 (6) (2019)
Enric Reverter, Juan J Lozano, Cristina Alonso, Annalisa Berzigotti, Susana Seijo, Fanny Turon, Anna Baiges, Mari L Martínez-Chantar, José M Mato, Ibon Martínez-Arranz, Vincenzo la Mura, Virginia Hernández-Gea, Jaume Bosch, Joan Carles García-Pagán
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis. Liver international : official journal of the International Association for the Study of the Liver 39 (4) (2019)
Adrià Carpio, Anna Merino, Sergio Rodríguez-Tajes, Enric Reverter, Miquel Bruguera, Xavier Forns, Javier Fernández
Massive hemolysis complicating acute granulomatous hepatitis. Annals of hematology 97 (9) (2018)
Martina Gambato, Laetitia Canini, Sabela Lens, Frederik Graw, Elena Perpiñan, Maria-Carlota Londoño, Susan L Uprichard, Zoe Mariño, Enric Reverter, Concepcio Bartres, Patricia González, Anna Pla, Josep Costa, Patrizia Burra, Scott J Cotler, Xavier Forns, Harel Dahari
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis. Liver international : official journal of the International Association for the Study of the Liver 39 (5) (2018)